Biotech | December 13, 2021
Nova Nordisk to invest 17 bn Danish kroner to expand capacity in Denmark
The investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity
